Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - ALDA Pharmaceuticals Inc. - Exhibit 4e

DUFT BIOTECH CAPITAL LTD. 

Stock Option Incentive Plan

1.       
 PURPOSE

The purpose of this Stock Option Incentive Plan is to provide
an incentive to Eligible Persons to acquire a proprietary interest in the
Company, to continue their participation in the affairs of the Company and to
increase their efforts on behalf of the Company.

2.         
DEFINITIONS

In this Plan, the following words have the following
meanings:

	(a) 	 “Board” means the
        Board of Directors of the Company; 

	  	 	  

	(b) 	 “Common Shares” means
        the Common Shares of the Company; 

	  	 	  

	(c) 	 “Company” means Duft
        Biotech Capital Ltd.; 

	  	 	  

	(d) 	 “Effective Date” means
        the day following the date upon which the Plan has been approved by the
        last to approve of the shareholders of the Company, the Board and the
        TSX Venture 

	  	 	  

	(e) 	 “Eligible Person”
        means any director, senior officer, employee or consultant of the Company
        or any affiliate of the Company; 

	  	 	  

	(f) 	 “Exchange” means the
        TSX Venture Exchange and any other stock exchange or stock quotation system
        on which the Common Shares trade; 

	  	 	  

	(g) 	 “Fair Market Value”
        means, as of any date, the value of the Common Shares, determined as 

	  		  

		(i) 	 if the Common Shares are listed on the TSX
        Venture Exchange, the Fair Market Value shall be the last closing sales
        price for such shares as quoted on such Exchange for the market trading
        day immediately prior to the date of grant of the Option, less any discount
        permitted by the TSX Venture Exchange; 

	  	 	  

		(ii) 	 if the Common Shares are listed on an Exchange
        other than the TSX Venture Exchange, the fair market value shall be the
        closing sales price of such shares (or the closing bid, if no sales were
        reported) as quoted on such Exchange for the market trading day immediately
        prior to the time of determination less any discount permitted by such
        Exchange; and 

	  	 	  

		(iii) 	 if the Common Shares are not listed on an
        Exchange, the Fair Market Value shall be determined in good faith by the
        Board; 

		 	  

	(h) 	 “Investor Relations Activities”
        has the meaning set out in the policies of the TSX Venture 

2

	(i) 	
      “Option” means the option granted to an Optionee under
      this Plan and the Option Agreement;

	 	 
	(j) 	
      “Option Agreement” means such option agreement or
      agreements as is approved from time to time by the Board and as is not
      inconsistent with the terms of this Plan;

	 	 
	(k) 	
      “Option Date” means the date of grant of an Option to an
      Optionee;

	 	 
	(l) 	
      “Optionee” means a person to whom an Option has been
      granted;

	 	 
	(m) 	
      “Option Price” is the price at which the Optionee is
      entitled pursuant to the Plan and the Option Agreement to acquire Option
      Shares;

	 	 
	(n) 	
      “Option Shares” means, subject to the provisions of
      Article 8 of this Plan, the Common Shares which the Optionee is entitled
      to acquire pursuant to this Plan and the applicable Option Agreement;
      and

	 	 
	(o) 	
      “Plan” means this 2003 Stock Option Incentive
  Plan.

3.          ADMINISTRATION

The Plan shall be administered by the Board, and subject to the
rules of the Exchange from time to time and except as provided for herein, the
Board shall have full authority to:

	(a) 	 determine and designate from time to time those Eligible
        Persons to whom Options are to be granted and the number of Option Shares
        to be optioned to each such Eligible Person;

	 	 
	(b) 	 determine the time or times when, and the manner in
        which, each Option shall be exercisable and the duration of the exercise
        period;

	 	 
	(c) 	 determine from time to time the Option Price, provided
        such determination is not inconsistent with this Plan; and

	 	 
	(d) 	 interpret the Plan and to make such rules and regulations
        and establish such procedures as it deems appropriate for the administration
        of the Plan, taking into consideration the recommendations of management.

4.          OPTIONEES

Optionees must be Eligible Persons who, by the nature of their
jobs or their participation in the affairs of the Company, in the opinion of the
Board, are in a position to contribute to the success of the Company.

5.          EFFECTIVENESS
AND TERMINATION OF PLAN

The Plan shall be effective as of the Effective Date and shall
terminate on the earlier of:

	(a)	
      the date which is ten years from the Effective Date;
      and

	 	 
	(b) 	
      such earlier date as the Board may
  determine.

3

Any Option outstanding under the Plan at the time of
termination of the Plan shall remain in effect in accordance with the terms and
conditions of the Plan and the Option Agreement.

6.          THE
OPTION SHARES

The aggregate number of Option Shares reserved for issuance
under the Plan and Common Shares reserved for issuance under any other share
compensation arrangement granted or made available by the Company from time to
time may not exceed in aggregate 10% of the Company’s Common Shares issued and
outstanding at the time of grant.

7.          GRANTS,
TERMS AND CONDITIONS OF OPTIONS

Options may be granted by the Board at any time and from time
to time prior to the termination of the Plan. Options granted pursuant to the
Plan shall be contained in an Option Agreement and, except as hereinafter
provided, shall be subject to the following terms and conditions:

	(a) 	
      Option Price

	 	 
		
      The Option Price shall be determined by the Board,
      provided that such price shall not be lower than the Fair Market Value of
      the Option Shares on the date of grant of the Option.

	 	 
	(b) 	
      Duration and Exercise of Options

	 	 
		
      Except as otherwise provided elsewhere in this Plan, the
      Options shall be exercisable for a period to be determined in each
      instance by the Board, not exceeding ten years from the Option Date,
      provided that so long as the Company is classified as a “Tier 2” issuer by
      the TSX Venture Exchange, the Options shall be exercisable for a period
      not exceeding five years from the Option Date. The Options must be
      exercised in accordance with this Plan and the Option Agreement.

	 	 
		
      Except as contemplated in (c) below, no Option may be
      exercised by an Optionee who was an Eligible Person at the time of grant
      of such Option unless the Optionee shall have been an Eligible Person
      continuously since the Option Date. Absence on leave, with the approval of
      the Company, shall not be considered an interruption of employment for the
      purpose of the Plan.

	 	 
	(c) 	
      Termination

	 	 
		
      All rights to exercise Options shall terminate upon the
      earliest of:

	 	(i)	
      the expiration date of the Option;

	 	 	 
	 	(ii) 	
      the 30th day [if Tier 2, must be within 90
      days] after the Optionee ceases to be an Eligible Person for any
      reason other than death, disability or cause;

	 	 	 
	 	(iii) 	
      the 30th day after the Optionee who is engaged
      in Investor Relations Activities for the Company ceases to be employed to
      provide Investor Relations Activities;

	 	 	 
	 	(iv) 	
      the date on which the Optionee ceases to be an Eligible
      Person by reason or termination of the Optionee as an employee or
      consultant of the Company for

4

	 		
      cause (which, in the case of a consultant, includes any
      breach of an agreement between the Company and the consultant);

	 	 	 
	 	(v) 	
      the first anniversary of the date on which the Optionee
      ceases to be an Eligible Person by reason of termination of the Optionee
      as an employee or consultant on account of disability; or

	 	 	 
	 	(vi) 	
      the first anniversary of the date of death of the
      Optionee. (d)

Transferability of Option

Options are non-transferable and non-assignable. (e)

Other Terms and Conditions

The Option Agreement may contain such other provisions as the
Board deems appropriate, provided such provisions are not inconsistent with the
Plan and the requirements of the TSX Venture Exchange.

In addition, for as long as the Common Shares of the Company
are listed on the TSX Venture Exchange, the Company shall comply with the
following requirements:

	 	(i) 	
      so long as the Company is classified as a “Tier 2” issuer
      by the TSX Venture Exchange, Options to acquire more than 5% of the issued
      and outstanding Common Shares of the Company may not be granted to any one
      individual in any 12 month period;

	 	 	 
	 	(ii)	
      Options to acquire more than 2% of the issued and
      outstanding Common Shares of the Company may not be granted to any one
      consultant in any 12 month period;

	 	 	 
	 	(iii)	
      Options to acquire more than an aggregate of 2% of the
      issued and outstanding Common Shares of the Company may not be granted to
      an employee conducting Investor Relations Activities in any 12 month
      period;

	 	 	 
	 	(iv) 	
      the approval of the disinterested shareholders of the
      Company shall be obtained for any amendment to or reduction in the
      exercise price of the Option if the Optionee is an insider of the Company
      at the time of the amendment. For the purposes of this subsection, the
      term “insider” has the meaning assigned in the Securities Act
      (British Columbia); and

	 	 	 
	 	(v) 	
      for Options granted to the employees, consultants or
      management company employees of the Company, the Company will represent
      that the Optionee is a bona fide employee, consultant or management
      company employee of the Company, as the case may
be.

5

8.         
ADJUSTMENT OF AND CHANGES IN THE OPTION SHARES

	(a) 	
      If the Option Shares are at any time to be listed on any
      stock exchange or quoted on any stock exchange or stock quotation system
      other than the TSX Venture Exchange, to the extent that there are any
      Options which are outstanding and unexercised at the time of such
      application for listing, the Option Price, the aggregate number of Option
      Shares, the exercise period, and any other relevant terms of such Options,
      and the Option Agreements in relation thereto, shall be amended in
      accordance with the requirements of any applicable securities regulation
      or law or any applicable governmental or regulatory body (including the
      Exchange). Subject to the requirements of the Exchange, any such amendment
      shall be effective upon receipt of Board approval of it, and the approval
      of any of the shareholders of the Company or any of the Optionees is not
      required to give effect to such amendment. 

	  	
       

	(b) 	
      If the Option Shares, as presently constituted, are
      changed into or exchanged for a different number or kind of shares or
      other securities of the Company or of another Company (whether by reason
      of merger, consolidation, amalgamation, recapitalization,
      reclassification, split, reverse split, combination of shares, or
      otherwise) or if the number of such Option Shares are increased through
      the payment of a stock dividend, then there shall be substituted for or
      added to each Option Share subject to or which may become subject to an
      Option under this Plan, the number and kind of shares or other securities
      into which each outstanding Option Share is so changed, or for which each
      such Option Share is exchanged, or to which each such Option Share is
      entitled, as the case may be. Outstanding Options under the Option
      Agreements shall also be appropriately amended as to price and other terms
      as may be necessary to reflect the foregoing events. In the event that
      there is any other change in the number or kind of the outstanding Option
      Shares or of any shares or other securities into which such Option Shares
      are changed, or for which they have been exchanged, then, if the Board
      shall, in its sole discretion, determine that such change equitably
      requires an adjustment in any Option theretofore granted or which may be
      granted under the Plan, such adjustment shall be made in accordance with
      such determination. 

	  	
       

	(c) 	
      Fractional shares resulting from any adjustment in
      Options pursuant to this Section 8 will be cancelled. Notice of any
      adjustment shall be given by the Company to each holder of an Option which
      has been so adjusted and such adjustment (whether or not such notice is
      given) shall be effective and binding for all purposes of the Plan.
  

9.         
PAYMENT

Subject as hereinafter provided, the full purchase price for
each of the Option Shares shall be paid by certified cheque in favour of the
Company upon exercise thereof. An Optionee shall have none of the rights of a
shareholder in respect of the Option Shares until the shares are issued to such
Optionee.

6

10.         SECURITIES
LAW REQUIREMENTS

No Option shall be exercisable in whole or in part, nor shall
the Company be obligated to issue any Option Shares pursuant to the exercise of
any such Option, if such exercise and issuance would, in the opinion of counsel
for the Company, constitute a breach of any applicable laws from time to time,
or the rules from time to time of the Exchange. Each Option shall be subject to
the further requirement that if at any time the Board determines that the
listing or qualification of the Option Shares under any securities legislation
or other applicable law, or the consent or approval of any governmental or other
regulatory body (including the Exchange), is necessary as a condition of, or in
connection with, the issue of the Option Shares hereunder, such Option may not
be exercised in whole or in part unless such listing, qualification, consent or
approval has been effected or obtained free of any conditions not acceptable to
the Board.

11.          AMENDMENT
OF THE PLAN

	(a) 	
      The Board may amend, suspend or terminate the Plan or any
      portion thereof at any time, but an amendment may not be made without
      shareholder approval if such approval is necessary to comply any
      applicable regulatory requirement.

	(b) 	
      The Board shall have the power, in the event
of:

	 	 	 
		(i) 	
      any disposition of substantially all of the assets of the
      Company, dissolution or any merger, amalgamation or consolidation of the
      Company, with or into any other Company, or the merger, amalgamation or
      consolidation of any other Company with or into the Company; or

	 	 	 
		
      (ii)
	 any acquisition pursuant to a public tender offer
      of a majority of the then issued and outstanding Common Shares;
	 	 	 
		
      but subject to compliance with the rules of the Exchange,
      to amend any outstanding Options to permit the exercise of all such
      Options prior to the effectiveness of any such transaction, and to
      terminate such Options as of such effectiveness in the case of
      transactions referred to in subsection (i) above, and as of the
      effectiveness of such tender offer or such later date as the Board may
      determine in the case of any transaction described in subsection (ii)
      above. If the Board exercises such power, all Options then outstanding and
      subject to such requirements shall be deemed to have been amended to
      permit the exercise thereof in whole or in part by the Optionee at any
      time or from time to time as determined by the Board prior to the
      effectiveness of such transaction, and such Options shall also be deemed
      to have terminated as provided above.

12.          SHAREHOLDER
APPROVAL

This Plan is subject to the approval of the shareholders of the
Company yearly at each annual general meeting of the Company. Any Options
granted prior to such approval are conditional upon such approval being given,
and no such Options may be exercised unless and until such approval is
given.

Shareholder approval received at the meeting held June 20,
2003; TSX Venture Exchange approval received November 14, 2003.Filed by Automated Filing Services Inc. (604) 609-0244 - ALDA Pharmaceuticals Inc. - Exhibit 4f

DISTRIBUTORSHIP AGREEMENT

THIS AGREEMENT made as of the 28th day of June,
2004, with effect from the 1st day of August, 2004 (the “Effective Date”).

BEWEEN:

ALDA PHARMACEUTICALS CORP., a
corporation existing under the laws of the Province of British Columbia, Canada
and having its principal address at: 635 Columbia Street, New Westminster, BC
V3M 1A7 CANADA

(the “Company”)

AND:

LINNS CORPORATION SHD BHD, a
corporation existing under the laws of Malaysia and having its principal address
at: 46, Jalan USJ 11/1B, 47620 UEP Subang Jaya, Selangor Darul Ehsan
MALAYSIA

(the “Distributor”)

WHEREAS the Distributor desires to be appointed by the Company
as Distributor of the Company's ViralexTM disinfectant and other
products as may become available (“the Products”) in the territory hereinafter
described and subject to the provisions set forth herein. 

NOW THEREFORE in consideration of the premises and the mutual
covenants herein set forth, it is agreed by and between the parties as follows:

	1. 	
      Appointment as Distributor

	 	 	 
	1.01 	
      Subject to the terms and conditions set forth in this
      Agreement, the Company hereby appoints the Distributor as a distributor in
      the territories as set out in Schedule “B” hereto, subject to the required
      applications for approval and registration of the Products being submitted
      by the Distributor (the "Territory"), to purchase from the Company for
      resale in the Territory those particular products of the Company described
      in Schedule “A” hereto (the “Products”).

	 	 	 
	1.02 	
      The Distributor accepts such appointment and agrees as
      follows:

	 	 	 
		(a) 	
      To use its best commercial efforts to develop the market
      for the Product in the Territory and to engage sufficient personnel in
      said territory to aggressively promote the sale of the Product throughout
      the Territory.

	 	 	 
		(b) 	
      To become familiar with the characteristics and purposes
      of the Products, and the markets for which they are intended to be used,
      and to diligently review all product

	 		
      information in connection with the Product which may be
      issued to the Distributor from time to time.

	 	 	 
	 	(c) 	
      To conform faithfully to the Company's sales plans and
      policies.

	 	 	 
	 	(d) 	
      To refrain from entering into or knowingly directly or
      indirectly facilitating the sale or resale of any Products outside of the
      Territory.

	 	 	 
	 	(e) 	
      To refrain from selling or offering for sale any items
      manufactured by others which are similar or functionally the same as the
      Products and which would reasonably be seen as being competitive to the
      Products.

	 	 	 
	 	(f) 	
      To comply with any and all laws, regulations and
      governmental orders of the Territory that may be applicable to the sale
      and distribution of the merchandise purchased by the Distributor from the
      Company.

	 	 	 
	 	(g) 	
      To indemnify the Company and hold it harmless from and
      against any and all claims, suits, proceedings, judgments, orders, fines
      or penalties arising in connection with the conduct of the Distributor’s
      business and the resale of Products by the Distributor except for such
      claims arising out of Company's sole negligent or intentional wrongful
      acts or omissions.

	1.03 	
      The appointment of the Distributor shall be exclusive for
      the sale of the Products during the Initial Term of this Agreement (as
      defined in Paragraph 6 below), and shall continue to be exclusive during
      any extension of this Agreement beyond the Initial Term PROVIDED that the
      Distributor meets the Minimum Purchase Obligations set out in Paragraph 3
      below.

	 	 
	1.04 	
      The Distributor expressly acknowledges and agrees that it
      is not an agent of Company and shall not at any time represent itself as
      such, nor shall the Distributor incur, assume or create any debt,
      obligation, contract or release of any kind in the name of or on behalf of
      Company.

	 	 
	1.05 	
      All trademarks, copyrights, trade names and other
      proprietary rights in and with respect to the Company's products and
      services, are and will remain the exclusive property of Company. Nothing
      herein shall be deemed to constitute a license to the Distributor to use
      the Company's trademarks in connection with its business in the
      Territory.

	 	 
	2. 	
      Prices

	 	 
	2.01 	
      The Distributor shall purchase Product's from the
      Company, for the purpose of resale within the Territory. The company and
      the Distributor will work closely to create a pricing strategy that will
      ensure the competitiveness of the company’s products and enhance the
      opportunity for the success of the Distributor within the territory. The
      Distributor expressly acknowledges and agrees that the Company shall have
      the right at any time during the term of this Agreement to increase or
      decrease its selling prices

2

		
      to the Distributor subject only to providing the
      Distributor with not less than 45 days prior notice of any price
      increase.

	 	 
	2.02 	
      All costs, including but not limited to shipping,
      collections, taxes, exchange, license fees, stamps, and all charges
      thereon are the Distributor's responsibility.

	 	 
	3. 	
      Product Orders

	 	 
	3.01 	
      Within 120 days after the Effective Date, the Distributor
      and the Company covenant to determine mutually agreeable minimum purchase
      obligations for the first 12 month period of this Agreement (the “Minimum
      Purchase Obligations”). Within 12 months after the Effective Date, the
      Distributor and the Company covenant to determine mutually agreeable
      minimum purchase obligations the Minimum Purchase Obligations for the
      ensuing 4 years of this Agreement.

	 	 
	3.02 	
      While the Company will endeavor to accept all orders for
      reasonable quantities submitted by the Distributor hereunder, it is
      expressly agreed that all orders are subject to written acceptance by the
      Company, as in its sole discretion it shall determine, and no order shall
      be the commitment of the Company until written acceptance thereof has been
      delivered to the Distributor by the Company, and such acceptance shall be
      subject to all of the provisions of both this Agreement and the Company's
      acknowledgment.

	 	 
	4. 	
      Payment Terms

	 	 
	4.01 	
      Full payment in the form of cash, certified funds, or an
      irrevocable letter of credit must accompany all orders. In the event any
      order submitted by the Distributor is cancelled by the Distributor for any
      reason before shipment, the Distributor shall pay any loss or damage to
      the Company. The Company will not be liable for failure to perform under
      this Agreement, if such failure shall be due to fire or to labor, material
      or car shortage, or to strikes, lock-outs, public enemies, Acts of God, or
      causes beyond Company's control.

	 	 
	5. 	
      Warranties and Limitation of Liability

	 	 
	5.01 	
      The Company warrants that it has good and marketable
      title to the merchandise sold to the Distributor hereunder. NO OTHER
      EXPRESS OR IMPLIED WARRANTY IS

	 	 
		
      MADE WITH RESPECT TO MERCHANDISE SOLD HEREUNDER, SUCH
      BEING SUBJECT TO WARRANTIES MADE BY THEIR RESPECTIVE MANUFACTURERS. THE
      COMPANY'S TOTAL LIABILITY TO THE DISTRIBUTOR RESULTING FROM THE SALE OF
      MERCHANDISE SHALL NOT EXCEED THE PRICE PAID BY THE DISTRIBUTOR FOR SUCH
      MERCHANDISE. The Distributor agrees not to return any merchandise to the
      Company except in compliance with the Company's standard return policy for
      defective merchandise (Schedule “C”).

3

	6. 	
      Term of Agreement

	 	 
	6.01 	
      This Agreement shall be effective commencing on the
      Effective Date first above written, and shall continue for an initial term
      of five years (the “Initial Term”). Upon expiration of the Initial Term,
      and providing that the minimum sales levels have been met, this Agreement
      may be renewed for a further five-year period. The terms of such renewal
      will reflect current market conditions in the territory.

	 	 
	6.02 	
      The Company reserves the right to terminate this
      Agreement at any time: (i) upon ten (10) days advance written notice in
      the event that any payment owing to Company for Product supplied to the
      Distributor is not received within thirty (30) days after the date on
      which such payment is due; or (ii) immediately upon written notice of
      termination by the Company in the event that the Distributor is in breach
      of any provision hereof, including without limitation any failure to meet
      a Minimum Purchase Obligation as set out in section 3.01, and fails to
      cure such breach following written notice of breach by the Company and a
      reasonable period to cure such breach, which need not exceed thirty (30)
      days from the date of notice. The Agreement may also, at the option of the
      Company, be terminated immediately if the Distributor becomes insolvent;
      violates the laws, regulations, rules, or statutes of any government;
      ceases doing business; makes an assignment for the benefit of creditors;
      or commits an act of bankruptcy. The Company's failure to exercise any
      right hereunder shall not operate as a waiver of such right and all
      remedies contained herein shall be cumulative.

	 	 
	7. 	
      Right of First Refusal

	 	 
	7.01 	
      For a period of 12 months after the date that the
      Distributor establishes the Minimum Purchase Obligations for the first
      year of this Agreement according the conditions of Paragraph 3.01 of this
      Agreement, the Company grants to the Distributor a Right of First Refusal
      to establish a joint venture agreement with the Company for the purpose of
      manufacturing ViralexTM .

	 	 
	8. 	
      Conflict of Laws

	 	 
	8.01 	
      Any part of this Agreement that is contrary to any
      federal, state, or local law shall not be applicable and shall not
      invalidate any other part of this Agreement. In the event of disputes or
      legal interpretation of the terms of this Agreement, the laws of British
      Columbia, Canada shall govern and be binding upon the parties
    hereto.

	 	 
	9. 	
      Entire Agreement

	 	 
	9.01 	
      This Agreement contains the entire understanding of the
      parties and there are no commitments, agreements, or understandings
      between the parties other than those expressly set forth herein. This
      Agreement shall not be altered, waived, modified, or amended except in
      writing signed by the parties hereto and
notarized.

4

	10. 	
      Dispute Resolution

	 	 
	10.01 	
      All disputes arising out of or in connection with the
      present contract shall be finally settled under the Rules of Arbitration
      of the International Chamber of Commerce by one or more arbitrators
      appointed in accordance with the said Rules. The place of arbitration
      shall be Vancouver, British Columbia or such other location as may be
      agreed to by both parties.

	 	 
	11. 	
      Confidentiality

	 	 
	11.01 	
      The Distributor agrees not to disclose or use, except as
      required in the Distributor's duties, at any time, any information
      disclosed to or acquired by the Distributor during the term of this
      contract. The Distributor agrees that all confidential information shall
      be deemed to be and shall be treated as a sole and exclusive property of
      the Company.

	 	 
	12. 	
      Governing Law

	 	 
	12.01 	
      This Agreement shall be governed by and be construed in
      accordance to the laws of the Province of British Columbia,
  Canada.

	 	 
	12.02 	
      The parties agree that the provisions of the United
      Nations Convention on Contracts for the International Sale of Goods will
      not apply to the transactions contemplated by this Agreement.

	 	 
	13. 	
      Notices

	 	 
	13.01 	
      Any and all notices herein shall be in writing and may be
      transmitted by facsimile provided a copy shall be sent by certified mail,
      return receipt requested, to the addresses set forth at the head of this
      Agreement.

	 	 
	14. 	
      Execution

	 	 
	14.01 	
      This Agreement may be signed by the authorized
      signatories of the Distributor and the Company by facsimile and in as many
      counterparts as may be necessary, each of which shall together constitute
      one and the same instrument, and notwithstanding the date of execution
      shall be deemed to bear the date as set out above. Original copies in as
      many counterparts as may be necessary shall follow by mail.

	 	 
	15. 	
      Assignment

	 	 
	15.01 	
      This Agreement and the rights, duties and obligations
      hereunder may not be assigned or delegated by either party without the
      prior written consent of the other party.

IN WITNESS WHEREOF, the parties hereto have executed this
Agreement the day and year first above written. 

5

	LINNS CORPORATION SHD BHD 	 
	By its duly authorized signatory: 	 
	  	 
	  	 
	  	 
	“Shirley Sim Hong Siang” 	 
	Shirley Sim Hong Siang. Managing Director 	 
	  	 
	ALDA PHARMACEUTICALS CORP. 	 
	By its duly authorized signatories: 	 
	  	 
	  	 
	“Terrance G. Owen” 	 
	Signature 	 
	Terrance G. Owen, President & CEO 	 
	  	 
	  	 
	“Peter Chen” 	 
	Signature 	 
	Peter Chen, CFO 	 

6

SCHEDULE “A”

THE PRODUCTS

ViralexTM (Scented and unscented)

	30 milliliter (Personal Protection Plus)
  
	480 milliliter sprayer bottles
  
	1 liter bottles
  
	4 liter jugs
  
	20 litre Sanipaks
  
	200 litre drums 

 

 

7

SCHEDULE “B”

THE TERRITORY

For the purposes hereof, the Territory shall consist of the
following countries, in each case, as they are presently constituted:

Brunei 
Cambodia 
Indonesia 
Japan 
Laos

Malaysia 
Myanmar 
Philippines 
Singapore 
South Korea

Taiwan 
Thailand 
Vietnam

 

 

 

8

SCHEDULE “C”

STANDARD RETURN POLICY

	1. 	
      The parties agree that during the term of this Agreement
      ALDA shall:

	 	 	 
		a. 	
      Warrant that the Products shall comply in all respects
      with the specifications as defined in the technical data sheets, and in
      the event that Products are found to not comply with the technical data
      sheets, will replace the Products with Products that do so
  comply;

	 	 	 
		b. 	
      Replace any of the Products at no cost that are found by
      ALDA or the Distributor to have an inherent defect and bear all costs
      related to the replacement of those Products. However, in the event of
      such a claim all the relevant product and usage details, as specified by
      ALDA, must be made available to ALDA. An investigational report will be
      submitted to the Distributor. Products will not be replaced if deemed by
      ALDA to be defective due to incorrect handling or usage.

	 	 	 
	2. 	
      Any of the Products which are to be returned to ALDA for
      replacement or credit, shall be shipped to ALDA at ALDA’s cost with
      fifteen days of receipt by the Distributor.

 

 

9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]